GTA Mining and Resources Inc. (CVE:GTA), a gold junior, announced assay results from its Northshore Property
Sean Mason | November 1, 2016 | SmallCapPower
One bad hole may have tarnished assays from a gold junior Tuesday. Here’s some small stocks making big moves on Tuesday, November 1, 2016 (as of 4 pm EST):
GTA Mining and Resources Inc. (CVE:GTA) shares sank 39% to $0.07 on Tuesday after the gold junior announced assay results from the second and final phase of the 2016 summer drill program on its Northshore Property in northern Ontario, which included 2.84 g/t gold over 14.5 metres. One hole, G-16-01, drilled to test the on-strike potential of the high grade Gino quartz vein system returned no appreciable values.
As well, shares of Wajax Corporation (TSE:WJX) rose 11% to $16.99 as the provider of rental and after-sale parts and service support of equipment, power systems and industrial components said it expects about $8 million of savings in 2016, $15 million in 2017, and that fourth-quarter earnings will continue to benefit from the earnings improvement initiatives implemented.
Voltaic Minerals Corp. (CVE:VLT), meanwhile, reported that it has signed an MOU with Enertrex Corporation to begin process development and optimization for the expected lithium brine solution extracted from the Green Energy Project in Utah using Enertrex’s Selective Lithium Process. Voltaic Minerals stock popped 58% to $0.095 following the announcement.
In addition, shares of Cymat Technologies Ltd. (CVE:CYM) jumped 77% to $0.31 as the industrial materials developer said it has signed of a Memorandum of Understanding with Alucoil, SA, a wholly-owned subsidiary of Aliberico SL, whereby Cymat and Alucoil will jointly deploy their respective proprietary technologies to develop, design, build and operate a manufacturing facility for the continuous production of aluminum foam composite panels.
Finally, Neovasc Inc. (TSE:NVC) shares plunged 38% to $0.85 after the specialty medical device company announced that the Federal District Court upheld a trial jury’s verdict in CardiAQ’s suit against Neovasc in May 2016. Neovasc has been ordered to pay US$70 million plus US$21 million in enhanced damages to that award.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.